Moving beyond angiotensin II to also target aldosterone?
- PMID: 19643311
- DOI: 10.1016/j.jacc.2009.03.064
Moving beyond angiotensin II to also target aldosterone?
Comment on
-
Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a randomized controlled trial.J Am Coll Cardiol. 2009 Aug 4;54(6):505-12. doi: 10.1016/j.jacc.2009.03.066. J Am Coll Cardiol. 2009. PMID: 19643310 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources